ArticleFrontiers in oncology2025

Zanubrutinib as a salvage therapy for ibrutinib-resistant chronic lymphocytic leukemia: a case report.

Zhenhui Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.